The FDA has a new regulatory framework for cannabidiol products is required that achieves a compromise between people's needs for access to CBD products and the monitoring institutions need to control dangers.
The FDA has a new regulatory framework for cannabidiol products is required that achieves a compromise between people's needs for access to CBD products and the monitoring institutions need to control dangers.
On September 22, 2022, the Philippines FDA published the Amendment to Administrative Order No.